42 studies found for:    " January 16, 2008":" February 15, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Active, not recruiting A Rollover Study for Subjects Who Completed Participation in the VRX496-USA-05-002 Trial
Condition: HIV Infections
Intervention: Genetic: VRX496-transduced autologous CD4 T cells
22 Completed ROCKET I - Randomized Open Label Switch for Cholesterol Elevation on Kivexa Evaluation Trial
Condition: HIV Infections
Interventions: Drug: Atripla;   Drug: Kivexa plus Sustiva
23 Completed
Has Results
Clinical Trial of CNS-targeted HAART (CIT2)
Condition: HIV Infections
Intervention: Drug: FDA Approved Antiretroviral Therapy (see list below)
24 Terminated Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection
Condition: HIV Infections
Interventions: Drug: apricitabine;   Drug: lamivudine
25 Completed Efficacy and Safety to Extend Treatment 24 Weeks in co-Infected HIV-HCV Genotype 1 and/or 4
Conditions: HIV Infections;   Hepatitis C
Intervention: Drug: Peginterferon alfa-2a + ribavirin
26 Completed Pharmacokinetic Study on Raltegravir and Lamotrigine
Condition: HIV Infection
Interventions: Drug: lamotrigine;   Drug: Raltegravir
27 Completed Evaluate the Efficacy and Security of Darunavir/Ritonavir 900/100 mg Once a Day as an Antiretroviral Treatment Simplification Strategy
Condition: HIV Infections
Interventions: Drug: Darunavir 900mg + ritonavir 100 mg once a day;   Drug: Darunavir 600mg + ritonavir 100mg twice day
28 Completed Pharmacokinetics of Low Dose Ritonavir
Condition: HIV Infections
Intervention: Drug: ritonavir and saquinavir
29 Completed Pharmacokinetics of Generic Lopinavir/Ritonavir in Pregnant Women
Condition: HIV Infections
Intervention: Drug: generic lopinavir/ritonavir
30 Completed Italian Prospective Data Collection for Better Patient Characterization in a Highly Treatment Experienced Population
Condition: HIV Infections
Intervention: Drug: TPV
31 Completed Utilization of HIV Drug Resistance Testing in Treatment Experienced Patients (UTILIZE Study)
Condition: HIV Infections
Intervention: Behavioral: NO BI Drug administered
32 Completed INNOVE Study: A Study of 3 Months Induction With Fuzeon (Enfuvirtide) + Optimized Background (OB) Versus OB Alone in HIV-1 Infected Patients With Virological Failure.
Condition: HIV Infections
Interventions: Drug: Optimized background ARV therapy;   Drug: enfuvirtide [Fuzeon]
33 Completed Clinical Trial to Assess the Security of the Dose Reduction of Ritonavir in HIV-Infected Patients in Treatment With Tipranavir/Ritonavir 500/200 mg Every 12 Hours
Condition: HIV Infections
Intervention: Drug: tipranavir/ritonavir (dose reduction)
34 Completed Nevirapine Drug Levels in HIV Positive Patients Also Receiving Rifampicin for Tuberculosis
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: Nevirapine without dose escalation;   Drug: Nevirapine initiation with dose escalation
35 Withdrawn Bioequivalence Study of Generic GPO Saquinavir and Norvir® Versus Invirase® and Norvir®
Condition: HIV Infections
Intervention: Drug: generic GPO saquinavir and novir vs invirase and norvir
36 Withdrawn Safety and Tolerability of a Therapeutic DNA Dendritic Cell Vaccine in HIV-Infected Children, Adolescents, and Young Adults
Condition: HIV Infections
Interventions: Biological: DermaVir patch;   Biological: Placebo patch
37 Completed
Has Results
Pharmaco-epidemiological Description of the Population Treated With Aptivus Under Market Conditions, Safety & Efficacy
Condition: HIV Infections
Intervention: Drug: tipranavir
38 Unknown  Efficacy of Group Intervention to Reduce Stress Symptoms
Conditions: Stress Disorders, Post-Traumatic;   HIV Infections
Intervention: Behavioral: HIV Skills-based Prevention
39 Active, not recruiting An Educational and Supportive Counseling Program for Increasing Antiretroviral Use and Adherence in People With HIV
Condition: HIV
Interventions: Behavioral: Counseling sessions;   Behavioral: Group workshop
40 Unknown  Two Different Treatments 24 vs 48 Weeks Chronic Hepatitis C Genotypes 2 and/or 3 in co-Infected HIV-HCV
Conditions: Chronic Hepatitis C;   Co-Infection HIV-HCV
Intervention: Drug: Peg interferon + Ribavirin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-42) Show next page of results    Last Page
Indicates status has not been verified in more than two years